Vertex Pharmaceuticals (VRTX) Income Tax Expense & History | Stock Alarm

Demo Sign up Log In

Vertex Pharmaceuticals · Income Tax Expense

VRTX Income Tax Expense

Latest reported$869.30Mperiod endingJun 30, 2026

VRTX Income Tax ($4.30M → $869.30M)

Annual income tax expense

High-resolution chart · PNG

VRTX income tax expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Income Tax Expense — Annual fiscal periods (USD)
Period ending	Income Tax Expense (USD)
Dec 31, 2025	690,000,000
Dec 31, 2024	784,100,000
Dec 31, 2023	760,200,000
Dec 31, 2022	910,400,000
Dec 31, 2021	388,300,000
Dec 31, 2020	405,151,000
Dec 31, 2019	218,109,000
Dec 31, 2018	-1,486,862,000
Dec 31, 2017	-107,324,000
Dec 31, 2016	16,665,000
Dec 31, 2015	30,381,000
Dec 31, 2014	6,958,000
Dec 31, 2013	-288,567,000
Dec 31, 2012	38,754,000
Dec 31, 2011	19,266,000
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	-30,729,000
Dec 31, 2007	-21,394,000
Dec 31, 2006	-18,496,000
Dec 31, 2005	61,679,000
Dec 31, 2004	29,014,000
Dec 31, 2003	24,064,000
Dec 31, 2002	-10,983,000
Dec 31, 2001	-1,916,000
Dec 31, 2000	976,000
Dec 31, 1999	1,400,000
Dec 31, 1998	700,000
Dec 31, 1997	600,000
Dec 31, 1996	10,200,000
Dec 31, 1995	-5,000,000
Dec 31, 1994	-3,100,000
Dec 31, 1993	100,000
Dec 31, 1992	-1,500,000
Dec 31, 1991	-500,000
Dec 31, 1990	4,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.